Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 22

Sort by

Sort Order Select

Meeting Abstracts

1350-P: Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study

KWOK LEUNG ONG, RACHEL L. O'CONNELL, ANDRZEJ S. JANUSZEWSKI, MARK W. DONOGHOE, VAL GEBSKI, DAVID SULLIVAN, KERRY ANN RYE, RUSSELL S. SCOTT, JAMES D. BEST, MARJA-RIITTA TASKINEN, ROBERT J. SIMES, ALICIA JENKINS, ANTHONY C. KEECH

Diabetes 2023;72(Supplement_1):1350-P

https://doi.org/10.2337/db23-1350-P

Published: 20 June 2023

View article titled, 1350-P: Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study

Meeting Abstracts

22-LB: Baseline and Short-Term Change in Plasma Uric Acid on Fenofibrate Predict Cardiovascular Risk: A Post Hoc Analysis of FIELD

JACOB YIMING CAO, BORIS WALDMAN, RACHEL L. OCONNELL, DAVID SULLIVAN, VAL GEBSKI, ANDRZEJ S. JANUSZEWSKI, IAN MARSCHNER, RUSSELL SCOTT, MARJA-RIITTA TASKINEN, R. JOHN SIMES, NEIL MCGILL, ALICIA J. JENKINS, ANTHONY C. KEECH

Diabetes 2019;68(Supplement_1):22-LB

https://doi.org/10.2337/db19-22-LB

Published: 01 June 2019

View article titled, 22-LB: Baseline and Short-Term Change in Plasma Uric Acid on Fenofibrate Predict Cardiovascular Risk: A Post Hoc Analysis of FIELD

Meeting Abstracts

23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial

STEVEN R. JONES, ALICIA J. JENKINS, ANDRZEJ S. JANUSZEWSKI, RACHEL L. OCONNELL, LIPING LI, DAVID SULLIVAN, MARJA-RIITTA TASKINEN, RUSSELL SCOTT, GERALD FRANCIS WATTS, PHILIP J. BARTER, R. JOHN SIMES, PETER P. TOTH, ANTHONY C. KEECH

Diabetes 2019;68(Supplement_1):23-LB

https://doi.org/10.2337/db19-23-LB

Published: 01 June 2019

View article titled, 23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial

Meeting Abstracts

41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial

PETER P. TOTH, ANTHONY C. KEECH, ANDRZEJ S. JANUSZEWSKI, RACHEL L. OCONNELL, LIPING LI, DAVID SULLIVAN, MARJA-RIITTA TASKINEN, PAUL L. DRURY, ESQ., GERALD FRANCIS WATTS, JAMES D. BEST, JEAN CLAUDE ANSQUER, STEVEN R. JONES, ALICIA J. JENKINS

Diabetes 2019;68(Supplement_1):41-LB

https://doi.org/10.2337/db19-41-LB

Published: 01 June 2019

View article titled, 41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial

Journal Articles

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Anne Hiukka, Marcus Ståhlman, Camilla Pettersson, Malin Levin, Martin Adiels, Susanne Teneberg, Eeva S. Leinonen, Lillemor Mattsson Hultén, Olov Wiklund, Matej Orešič, Sven-Olof Olofsson, Marja-Riitta Taskinen, Kim Ekroos, Jan Borén

Diabetes 2009;58(9):2018–2026

https://doi.org/10.2337/db09-0206

Published: 05 June 2009

View article titled, ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Includes: Supplementary data

Journal Articles

Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations

Diabetes 2008;57(11):3112–3121

https://doi.org/10.2337/db08-0516

Published: 01 November 2008

View article titled, Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations

Includes: Supplementary data

Journal Articles

Common Hepatic Nuclear Factor-4α Variants Are Associated With High Serum Lipid Levels and the Metabolic Syndrome

Daphna Weissglas-Volkov, Adriana Huertas-Vazquez, Elina Suviolahti, Jenny Lee, Christopher Plaisier, Samuel Canizales-Quinteros, Teresa Tusie-Luna, Carlos Aguilar-Salinas, Marja-Riitta Taskinen, Päivi Pajukanta

Diabetes 2006;55(7):1970–1977

https://doi.org/10.2337/db06-0035

Published: 01 July 2006

View article titled, Common Hepatic Nuclear Factor-4α Variants Are Associated With High Serum Lipid Levels and the Metabolic Syndrome

Includes: Supplementary data

Journal Articles

Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes

Valeriya Lyssenko, Peter Almgren, Dragi Anevski, Roland Perfekt, Kaj Lahti, Michael Nissén, Bo Isomaa, Björn Forsen, Nils Homström, Carola Saloranta, Marja-Riitta Taskinen, Leif Groop, Tiinamaija Tuomi, for the Botnia Study Group

Diabetes 2005;54(1):166–174

https://doi.org/10.2337/diabetes.54.1.166

Published: 01 January 2005

View article titled, Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes

Journal Articles

Relationship of Phospholipid Transfer Protein Activity to HDL and Apolipoprotein B-Containing Lipoproteins in Subjects With and Without Type 1 Diabetes

Helen M. Colhoun, Marja-Riitta Taskinen, James D. Otvos, Paul van den Berg, John O’Connor, Arie Van Tol

Diabetes 2002;51(11):3300–3305

https://doi.org/10.2337/diabetes.51.11.3300

Published: 01 November 2002

View article titled, Relationship of Phospholipid Transfer Protein Activity to HDL and Apolipoprotein B-Containing Lipoproteins in Subjects With and Without Type 1 Diabetes

Journal Articles

Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects

Leif Groop, Carol Forsblom, Mikko Lehtovirta, Tlinamaija Tuomi, Samuel Karanko, Michael Nissén, Bjorn-Olof Ehrnström, Björn Forsén, Bo Isomaa, Börje Snickars, Marja-Riitta Taskinen

Diabetes 1996;45(11):1585–1593

https://doi.org/10.2337/diab.45.11.1585

Published: 01 November 1996

View article titled, Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects

Journal Articles

Multiple Lipoprotein Abnormalities in Type I Diabetic Patients With Renal Disease

Per-Henrik Groop, Tom Elliott, Rogerio Friedman, GianCarlo Viberti, Agneta Ekstrand, Anja-Kallunki Franssila, Marja-Riitta Taskinen

Diabetes 1996;45(7):974–979

https://doi.org/10.2337/diab.45.7.974

Published: 01 July 1996

View article titled, Multiple Lipoprotein Abnormalities in Type I Diabetic Patients With Renal Disease

Journal Articles

Criteria for Metabolic Control and Intervention in Diabetes

Marja-Riitta Taskinen

Diabetes 1996;45(Supplement_3):S120–S122

https://doi.org/10.2337/diab.45.3.S120

Published: 01 July 1996

View article titled, Criteria for Metabolic Control and Intervention in Diabetes

Journal Articles

Metabolic Consequences of Sustained Suppression of Free Fatty Acids by Acipimox in Patients With NIDDM

Carola Saloranta, Marja-Riitta Taskinen, Elisabeth Widén, Matti Härkönen, Arne Melander, Leif Groop

Diabetes 1993;42(11):1559–1566

https://doi.org/10.2337/diab.42.11.1559

Published: 01 November 1993

View article titled, Metabolic Consequences of Sustained Suppression of Free Fatty Acids by Acipimox in Patients With NIDDM

Journal Articles

Regulation of Apolipoprotein A-I–Containing Lipoproteins in IDDM

Juhani Kahri, Per-Henrik Groop, Giancarlo Viberti, Tom Elliott, Marja-Riitta Taskinen

Diabetes 1993;42(9):1281–1288

https://doi.org/10.2337/diab.42.9.1281

Published: 01 September 1993

View article titled, Regulation of Apolipoprotein A-I–Containing Lipoproteins in IDDM

Journal Articles

Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus

Marja-Riitta Taskinen

Diabetes 1992;41(Supplement_2):12–17

https://doi.org/10.2337/diab.41.2.S12

Published: 01 October 1992

View article titled, Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus

Journal Articles

Effect of Insulin Therapy on Metabolic Fate of Apolipoprotein B–Containing Lipoproteins in NIDDM

Marja-Riitta Taskinen, C J Packard, J Shepherd

Diabetes 1990;39(9):1017–1027

https://doi.org/10.2337/diab.39.9.1017

Published: 01 September 1990

View article titled, Effect of Insulin Therapy on Metabolic Fate of Apolipoprotein B–Containing Lipoproteins in NIDDM

Journal Articles

Bedtime Insulin for Suppression of Overnight Free–Fatty Acid, Blood Glucose, and Glucose Production in NIDDM

Marja-Riitta Taskinen, Timo Sane, Eero Helve, Sirkka-Liisa Karonen, Esko A Nikkilä, Hannele Yki-Järvinen

Diabetes 1989;38(5):580–588

https://doi.org/10.2337/diab.38.5.580

Published: 01 May 1989

View article titled, Bedtime Insulin for Suppression of Overnight Free–Fatty Acid, Blood Glucose, and Glucose Production in NIDDM

Journal Articles

Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia

Hannele Yki-Järvinen, Marja-Riitta Taskinen

Diabetes 1988;37(9):1271–1278

https://doi.org/10.2337/diab.37.9.1271

Published: 01 September 1988

View article titled, Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia

Journal Articles

Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy

Clifton Bogardus, Marja-Riitta Taskinen, Joanna Zawadzki, Stephen Lillioja, David Mott, Barbara V Howard

Diabetes 1986;35(1):1–5

https://doi.org/10.2337/diab.35.1.1

Published: 01 January 1986

View article titled, Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy

Journal Articles

No Evidence of Amyloidosis in Type I Diabetics Treated with Continuous Subcutaneous Insulin Infusion

Veikko A Koivisto, Anna-Maija Teppo, C Peter J Maury, Marja-Riitta Taskinen

Diabetes 1983;32(1):88–90

https://doi.org/10.2337/diab.32.1.88

Published: 01 January 1983

View article titled, No Evidence of Amyloidosis in Type I Diabetics Treated with Continuous Subcutaneous Insulin Infusion

NARROW

1350-P: Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study

22-LB: Baseline and Short-Term Change in Plasma Uric Acid on Fenofibrate Predict Cardiovascular Risk: A Post Hoc Analysis of FIELD

23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial

41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations

Common Hepatic Nuclear Factor-4α Variants Are Associated With High Serum Lipid Levels and the Metabolic Syndrome

Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes

Relationship of Phospholipid Transfer Protein Activity to HDL and Apolipoprotein B-Containing Lipoproteins in Subjects With and Without Type 1 Diabetes

Metabolic Consequences of a Family History of NIDDM (The Botnia Study): Evidence for Sex-Specific Parental Effects

Multiple Lipoprotein Abnormalities in Type I Diabetic Patients With Renal Disease

Criteria for Metabolic Control and Intervention in Diabetes

Metabolic Consequences of Sustained Suppression of Free Fatty Acids by Acipimox in Patients With NIDDM

Regulation of Apolipoprotein A-I–Containing Lipoproteins in IDDM

Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus

Effect of Insulin Therapy on Metabolic Fate of Apolipoprotein B–Containing Lipoproteins in NIDDM

Bedtime Insulin for Suppression of Overnight Free–Fatty Acid, Blood Glucose, and Glucose Production in NIDDM

Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia

Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy

No Evidence of Amyloidosis in Type I Diabetics Treated with Continuous Subcutaneous Insulin Infusion

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only